西班牙跨学科心血管预防委员会(CEIPC)对2012年欧洲心血管预防指南的评论

Miguel Angel Royo-Bordonada , José María Lobos Bejarano , Fernando Villar Alvarez , Susana Sans , Antonio Pérez , Juan Pedro-Botet , Rosa María Moreno Carriles , Antonio Maiques , Ángel Lizcano , Vicenta Lizarbe , Antonio Gil Núñez , Francisco Fornés Ubeda , Roberto Elosua , Ana de Santiago Nocito , Carmen de Pablo Zarzosa , Fernando de Álvaro Moreno , Olga Cortés , Alberto Cordero , Miguel Camafort Babkowski , Carlos Brotons Cuixart , Pedro Armario
{"title":"西班牙跨学科心血管预防委员会(CEIPC)对2012年欧洲心血管预防指南的评论","authors":"Miguel Angel Royo-Bordonada ,&nbsp;José María Lobos Bejarano ,&nbsp;Fernando Villar Alvarez ,&nbsp;Susana Sans ,&nbsp;Antonio Pérez ,&nbsp;Juan Pedro-Botet ,&nbsp;Rosa María Moreno Carriles ,&nbsp;Antonio Maiques ,&nbsp;Ángel Lizcano ,&nbsp;Vicenta Lizarbe ,&nbsp;Antonio Gil Núñez ,&nbsp;Francisco Fornés Ubeda ,&nbsp;Roberto Elosua ,&nbsp;Ana de Santiago Nocito ,&nbsp;Carmen de Pablo Zarzosa ,&nbsp;Fernando de Álvaro Moreno ,&nbsp;Olga Cortés ,&nbsp;Alberto Cordero ,&nbsp;Miguel Camafort Babkowski ,&nbsp;Carlos Brotons Cuixart ,&nbsp;Pedro Armario","doi":"10.1016/j.avdiab.2013.04.002","DOIUrl":null,"url":null,"abstract":"<div><p>Based on the two main frameworks for evaluating scientific evidence (SEC and GRADE) European cardiovascular prevention guidelines recommend interventions across all life stages using a combination of population-based and high-risk strategies with diet as the cornerstone of prevention. The evaluation of cardiovascular risk (CVR) incorporates HDL levels and psychosocial factors, a very high risk category, and the concept of age-risk. They also recommend cognitive-behavioural methods (e.g., motivational interviewing, psychological interventions) led by health professionals and with the participation of the patient's family, to counterbalance psychosocial stress and reduce CVR through the institution of positive habits such as a healthy diet, physical activity, smoking cessation, and adherence to treatment. Additionally, public health interventions — such as smoking ban in public areas or the elimination of trans fatty acids from the food chain — are also essential. Other innovations include abandoning antiplatelet therapy in primary prevention and the recommendation of maintaining blood pressure within the 130-139/80-85<!--> <!-->mmHg range in diabetic patients and individuals with high CVR. Finally, due to the significant impact on patient progress and medical costs, special emphasis is given to the low therapeutic adherence levels observed. In sum, improving cardiovascular prevention requires a true partnership among the political class, public administrations, scientific and professional associations, health foundations, consumer associations, patients and their families. Such partnership would promote population-based and individual strategies by taking advantage of the broad spectrum of scientific evidence available, from clinical trials to observational studies and mathematical models to evaluate population-based interventions, including cost-effectiveness analyses.</p></div>","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"29 4","pages":"Pages 95-107"},"PeriodicalIF":0.0000,"publicationDate":"2013-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2013.04.002","citationCount":"0","resultStr":"{\"title\":\"Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las Guías Europeas de Prevención Cardiovascular 2012\",\"authors\":\"Miguel Angel Royo-Bordonada ,&nbsp;José María Lobos Bejarano ,&nbsp;Fernando Villar Alvarez ,&nbsp;Susana Sans ,&nbsp;Antonio Pérez ,&nbsp;Juan Pedro-Botet ,&nbsp;Rosa María Moreno Carriles ,&nbsp;Antonio Maiques ,&nbsp;Ángel Lizcano ,&nbsp;Vicenta Lizarbe ,&nbsp;Antonio Gil Núñez ,&nbsp;Francisco Fornés Ubeda ,&nbsp;Roberto Elosua ,&nbsp;Ana de Santiago Nocito ,&nbsp;Carmen de Pablo Zarzosa ,&nbsp;Fernando de Álvaro Moreno ,&nbsp;Olga Cortés ,&nbsp;Alberto Cordero ,&nbsp;Miguel Camafort Babkowski ,&nbsp;Carlos Brotons Cuixart ,&nbsp;Pedro Armario\",\"doi\":\"10.1016/j.avdiab.2013.04.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Based on the two main frameworks for evaluating scientific evidence (SEC and GRADE) European cardiovascular prevention guidelines recommend interventions across all life stages using a combination of population-based and high-risk strategies with diet as the cornerstone of prevention. The evaluation of cardiovascular risk (CVR) incorporates HDL levels and psychosocial factors, a very high risk category, and the concept of age-risk. They also recommend cognitive-behavioural methods (e.g., motivational interviewing, psychological interventions) led by health professionals and with the participation of the patient's family, to counterbalance psychosocial stress and reduce CVR through the institution of positive habits such as a healthy diet, physical activity, smoking cessation, and adherence to treatment. Additionally, public health interventions — such as smoking ban in public areas or the elimination of trans fatty acids from the food chain — are also essential. Other innovations include abandoning antiplatelet therapy in primary prevention and the recommendation of maintaining blood pressure within the 130-139/80-85<!--> <!-->mmHg range in diabetic patients and individuals with high CVR. Finally, due to the significant impact on patient progress and medical costs, special emphasis is given to the low therapeutic adherence levels observed. In sum, improving cardiovascular prevention requires a true partnership among the political class, public administrations, scientific and professional associations, health foundations, consumer associations, patients and their families. Such partnership would promote population-based and individual strategies by taking advantage of the broad spectrum of scientific evidence available, from clinical trials to observational studies and mathematical models to evaluate population-based interventions, including cost-effectiveness analyses.</p></div>\",\"PeriodicalId\":100152,\"journal\":{\"name\":\"Avances en Diabetología\",\"volume\":\"29 4\",\"pages\":\"Pages 95-107\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.avdiab.2013.04.002\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Avances en Diabetología\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1134323013000707\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Avances en Diabetología","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1134323013000707","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

基于评估科学证据的两个主要框架(SEC和GRADE),欧洲心血管预防指南建议在所有生命阶段采用以人群为基础和高风险策略相结合的干预措施,并将饮食作为预防的基石。心血管风险(CVR)的评估包括HDL水平和心理社会因素,一个非常高的风险类别,以及年龄风险的概念。他们还建议在卫生专业人员的领导下,在患者家属的参与下,采用认知行为方法(例如,动机性访谈、心理干预)来平衡心理社会压力,并通过养成健康饮食、体育活动、戒烟和坚持治疗等积极习惯来减少CVR。此外,公共卫生干预措施——例如在公共场所禁止吸烟或从食物链中消除反式脂肪酸——也是必不可少的。其他创新包括在一级预防中放弃抗血小板治疗,并建议糖尿病患者和高CVR个体将血压维持在130-139/80-85 mmHg范围内。最后,由于对患者进展和医疗费用的重大影响,特别强调观察到的治疗依从性较低。总而言之,改善心血管疾病预防需要政治阶层、公共行政部门、科学和专业协会、卫生基金会、消费者协会、患者及其家属之间建立真正的伙伴关系。这种伙伴关系将促进基于人群和个人的战略,利用现有的广泛科学证据,从临床试验到观察性研究和数学模型,以评估基于人群的干预措施,包括成本效益分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las Guías Europeas de Prevención Cardiovascular 2012

Based on the two main frameworks for evaluating scientific evidence (SEC and GRADE) European cardiovascular prevention guidelines recommend interventions across all life stages using a combination of population-based and high-risk strategies with diet as the cornerstone of prevention. The evaluation of cardiovascular risk (CVR) incorporates HDL levels and psychosocial factors, a very high risk category, and the concept of age-risk. They also recommend cognitive-behavioural methods (e.g., motivational interviewing, psychological interventions) led by health professionals and with the participation of the patient's family, to counterbalance psychosocial stress and reduce CVR through the institution of positive habits such as a healthy diet, physical activity, smoking cessation, and adherence to treatment. Additionally, public health interventions — such as smoking ban in public areas or the elimination of trans fatty acids from the food chain — are also essential. Other innovations include abandoning antiplatelet therapy in primary prevention and the recommendation of maintaining blood pressure within the 130-139/80-85 mmHg range in diabetic patients and individuals with high CVR. Finally, due to the significant impact on patient progress and medical costs, special emphasis is given to the low therapeutic adherence levels observed. In sum, improving cardiovascular prevention requires a true partnership among the political class, public administrations, scientific and professional associations, health foundations, consumer associations, patients and their families. Such partnership would promote population-based and individual strategies by taking advantage of the broad spectrum of scientific evidence available, from clinical trials to observational studies and mathematical models to evaluate population-based interventions, including cost-effectiveness analyses.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Evaluación de la satisfacción del paciente diabético con la utilización del glucómetro portátil BGSTAR© mediante el cuestionario SATIGLU Escalas de cálculo del riesgo cardiovascular para pacientes con diabetes. ¿Qué son y de qué nos sirven? Reunión anual del grupo de trabajo «islotes pancreáticos» de la Sociedad Española de Diabetes Documento de consenso sobre el tratamiento con infusión subcutánea continua de insulina en el medio hospitalario Claves para avanzar hacia un rol más activo por parte del paciente con diabetes mellitus tipo 2 en España
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1